160 related articles for article (PubMed ID: 15022325)
1. Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis.
Setoguchi K; Misaki Y; Kawahata K; Shimada K; Juji T; Tanaka S; Oda H; Shukunami C; Nishizaki Y; Hiraki Y; Yamamoto K
Arthritis Rheum; 2004 Mar; 50(3):828-39. PubMed ID: 15022325
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis.
Hayami T; Funaki H; Yaoeda K; Mitui K; Yamagiwa H; Tokunaga K; Hatano H; Kondo J; Hiraki Y; Yamamoto T; Duong LT; Endo N
J Rheumatol; 2003 Oct; 30(10):2207-17. PubMed ID: 14528519
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
[TBL] [Abstract][Full Text] [Related]
4. Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor.
Miura S; Mitsui K; Heishi T; Shukunami C; Sekiguchi K; Kondo J; Sato Y; Hiraki Y
Exp Cell Res; 2010 Mar; 316(5):775-88. PubMed ID: 20026108
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. Prolonged ingestion of ovalbumin diet by Ova sensitized mice suppresses mBSA-induced arthritis.
Noviello Mde L; Batista NV; Dourado LP; Pereira RV; Oliveira AG; Menezes GB; Cara DC
Cell Immunol; 2013; 284(1-2):20-8. PubMed ID: 23916876
[TBL] [Abstract][Full Text] [Related]
7. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
[TBL] [Abstract][Full Text] [Related]
8. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation.
Shukunami C; Hiraki Y
Osteoarthritis Cartilage; 2001; 9 Suppl A():S91-101. PubMed ID: 11680695
[TBL] [Abstract][Full Text] [Related]
9. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.
Kusafuka K; Hiraki Y; Shukunami C; Kayano T; Takemura T
Acta Histochem; 2002; 104(2):167-75. PubMed ID: 12086337
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes.
Choi JK; Kim SW; Kim DS; Lee JY; Lee S; Oh HM; Ha YS; Yoo J; Park PH; Shin TY; Kwon TK; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2016 Jan; 290():1-9. PubMed ID: 26570984
[TBL] [Abstract][Full Text] [Related]
11. Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.
Miura S; Kondo J; Kawakami T; Shukunami C; Aimoto S; Tanaka H; Hiraki Y
Cancer Sci; 2012 Jul; 103(7):1311-8. PubMed ID: 22429838
[TBL] [Abstract][Full Text] [Related]
12. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
14. Localization of chondromodulin-I at the feto-maternal interface and its inhibitory actions on trophoblast invasion in vitro.
Miura S; Shukunami C; Mitsui K; Kondo J; Hiraki Y
BMC Cell Biol; 2011 Aug; 12():34. PubMed ID: 21849085
[TBL] [Abstract][Full Text] [Related]
15. Chondromodulin-I and tenomodulin: the negative control of angiogenesis in connective tissue.
Shukunami C; Hiraki Y
Curr Pharm Des; 2007; 13(20):2101-12. PubMed ID: 17627542
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes.
Oshima Y; Shukunami C; Honda J; Nishida K; Tashiro F; Miyazaki J; Hiraki Y; Tano Y
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1814-23. PubMed ID: 12714610
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells.
Hiraki Y; Mitsui K; Endo N; Takahashi K; Hayami T; Inoue H; Shukunami C; Tokunaga K; Kono T; Yamada M; Takahashi HE; Kondo J
Eur J Biochem; 1999 Mar; 260(3):869-78. PubMed ID: 10103018
[TBL] [Abstract][Full Text] [Related]
19. Is Taurolidine a candidate for treatment of rheumatoid arthritis?
Marcinkiewicz J; Głuszko P; Kontny E; Kwaśny-Krochin B; Bobek M; Wierzchowski W; Ciszek M; Maśliński W
Clin Exp Rheumatol; 2007; 25(2):211-8. PubMed ID: 17543144
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
